R R Love1, O M Ginsburg2, C N Coleman3. 1. The International Breast Cancer Research Foundation, Madison, USA. Electronic address: richardibcrf@gmail.com. 2. Women's College Research Institute, the University of Toronto, Toronto, Canada. 3. Division of Cancer Treatment and Diagnosis, The Radiation Research Program, National Cancer Institute, Bethesda, USA.
Abstract
BACKGROUND: The problems of cancer are increasing in low- and middle-income countries (LMCs), which now have significant majorities of the global case and mortality burdens. The professional oncology community is being increasingly called upon to define pragmatic and realistic approaches to these problems. PATIENTS AND METHODS: Focusing on mortality and case burden outcomes defines public health oncology or population-affecting cancer medicine. We use this focus to consider practical approaches. RESULTS: The greatest cancer burdens are in Asia. A public health oncology perspective mandates: first, addressing the major and social challenges of cancer medicine for populations: human rights, health systems, corruption, and our limited knowledge base for value-conscious interventions. Second, adoption of evolving concepts and models for sustainable development in LMCs. Third, clear and realistic statements of action and inaction affecting populations, grounded in our best cancer science, and attention to these. Finally, framing the goals and challenges for population-affecting cancer medicine requires a change in paradigm from historical top-down models of technology transfer, to one which is community-grounded and local-evidence based. CONCLUSION: Public health oncology perspectives define clear focus for much needed research on country-specific practical approaches to cancer control.
BACKGROUND: The problems of cancer are increasing in low- and middle-income countries (LMCs), which now have significant majorities of the global case and mortality burdens. The professional oncology community is being increasingly called upon to define pragmatic and realistic approaches to these problems. PATIENTS AND METHODS: Focusing on mortality and case burden outcomes defines public health oncology or population-affecting cancer medicine. We use this focus to consider practical approaches. RESULTS: The greatest cancer burdens are in Asia. A public health oncology perspective mandates: first, addressing the major and social challenges of cancer medicine for populations: human rights, health systems, corruption, and our limited knowledge base for value-conscious interventions. Second, adoption of evolving concepts and models for sustainable development in LMCs. Third, clear and realistic statements of action and inaction affecting populations, grounded in our best cancer science, and attention to these. Finally, framing the goals and challenges for population-affecting cancer medicine requires a change in paradigm from historical top-down models of technology transfer, to one which is community-grounded and local-evidence based. CONCLUSION: Public health oncology perspectives define clear focus for much needed research on country-specific practical approaches to cancer control.
Authors: Paul Farmer; Julio Frenk; Felicia M Knaul; Lawrence N Shulman; George Alleyne; Lance Armstrong; Rifat Atun; Douglas Blayney; Lincoln Chen; Richard Feachem; Mary Gospodarowicz; Julie Gralow; Sanjay Gupta; Ana Langer; Julian Lob-Levyt; Claire Neal; Anthony Mbewu; Dina Mired; Peter Piot; K Srinath Reddy; Jeffrey D Sachs; Mahmoud Sarhan; John R Seffrin Journal: Lancet Date: 2010-08-13 Impact factor: 79.321
Authors: Surbhi Grover; Onyinye D Balogun; Kosj Yamoah; Reinou Groen; Mira Shah; Danielle Rodin; Adam C Olson; Jeremy S Slone; Lawrence N Shulman; C Norman Coleman; Stephen M Hahn Journal: Front Oncol Date: 2015-04-08 Impact factor: 6.244
Authors: C Norman Coleman; Silvia C Formenti; Tim R Williams; Daniel G Petereit; Khee C Soo; John Wong; Nelson Chao; Lawrence N Shulman; Surbhi Grover; Ian Magrath; Stephen Hahn; Fei-Fei Liu; Theodore DeWeese; Samir N Khleif; Michael Steinberg; Lawrence Roth; David A Pistenmaa; Richard R Love; Majid Mohiuddin; Bhadrasain Vikram Journal: Front Oncol Date: 2014-11-19 Impact factor: 6.244
Authors: Heinz-Peter Schlemmer; Leonardo K Bittencourt; Melvin D'Anastasi; Romeu Domingues; Pek-Lan Khong; Zarina Lockhat; Ada Muellner; Maximilian F Reiser; Richard L Schilsky; Hedvig Hricak Journal: J Glob Oncol Date: 2017-09-08